NO20042089L - Fremgangsmate for a screene legemiddel som virker pa cellevegg - Google Patents

Fremgangsmate for a screene legemiddel som virker pa cellevegg

Info

Publication number
NO20042089L
NO20042089L NO20042089A NO20042089A NO20042089L NO 20042089 L NO20042089 L NO 20042089L NO 20042089 A NO20042089 A NO 20042089A NO 20042089 A NO20042089 A NO 20042089A NO 20042089 L NO20042089 L NO 20042089L
Authority
NO
Norway
Prior art keywords
cell wall
reporter protein
targeting site
acts
procedure
Prior art date
Application number
NO20042089A
Other languages
English (en)
Norwegian (no)
Inventor
Akihiro Kitamura
Ryohei Nakajima
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20042089L publication Critical patent/NO20042089L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20042089A 2001-10-22 2004-05-21 Fremgangsmate for a screene legemiddel som virker pa cellevegg NO20042089L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001323293 2001-10-22
PCT/JP2002/010932 WO2003035898A1 (fr) 2001-10-22 2002-10-22 Methode de criblage d'un medicament agissant sur la paroi cellulaire

Publications (1)

Publication Number Publication Date
NO20042089L true NO20042089L (no) 2004-05-21

Family

ID=19140207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042089A NO20042089L (no) 2001-10-22 2004-05-21 Fremgangsmate for a screene legemiddel som virker pa cellevegg

Country Status (9)

Country Link
US (1) US7459268B2 (es)
EP (1) EP1445327B1 (es)
JP (1) JP4204471B2 (es)
AT (1) ATE370243T1 (es)
CA (1) CA2464396A1 (es)
DE (1) DE60221883T2 (es)
ES (1) ES2294172T3 (es)
NO (1) NO20042089L (es)
WO (1) WO2003035898A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1445327B1 (en) 2001-10-22 2007-08-15 Dalichi Sankyo Company, Limited Method of screening drug acting on cell wall
KR20080052556A (ko) * 2005-09-22 2008-06-11 산또리 가부시키가이샤 세포벽 만노단백질을 인코딩하는 유전자 및 이의 용도
TWI428091B (zh) * 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
WO2020018888A1 (en) 2018-07-20 2020-01-23 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
CN115094142B (zh) * 2022-07-19 2024-05-28 中国医学科学院肿瘤医院 用于诊断肺肠型腺癌的甲基化标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950702634A (ko) 1992-07-08 1995-07-29 이. 아디에 융합 단백질을 생성시킴으로써 미생물 세포의 세포벽에 효소를 고정화시키는 방법(Process for Immobilizing Enzymes to the Cell Wall of a Microbial Cell by Producing a Fusion Protein)
JPH0956384A (ja) 1995-08-25 1997-03-04 Toray Ind Inc 細胞の標識方法
EP0916726A1 (en) 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Attaching substances to micro-organisms
WO1999067419A1 (en) 1998-06-25 1999-12-29 The Collaborative Group, Ltd. β(1,6)-GLUCAN SYNTHESIS AND CELL WALL ASSEMBLY ASSAY
JP2000102387A (ja) 1998-09-29 2000-04-11 Daicel Chem Ind Ltd 発光蛋白質発現組換えベクター、及びこの組換えベクターにより形質転換された酵母
CA2407906A1 (en) 2000-05-01 2001-11-08 Daiichi Pharmaceutical Co., Ltd. Method for screening agent acting on cell wall
EP1445327B1 (en) 2001-10-22 2007-08-15 Dalichi Sankyo Company, Limited Method of screening drug acting on cell wall

Also Published As

Publication number Publication date
EP1445327B1 (en) 2007-08-15
US20050069965A1 (en) 2005-03-31
EP1445327A1 (en) 2004-08-11
ATE370243T1 (de) 2007-09-15
DE60221883T2 (de) 2008-04-30
JPWO2003035898A1 (ja) 2005-02-10
ES2294172T3 (es) 2008-04-01
JP4204471B2 (ja) 2009-01-07
DE60221883D1 (de) 2007-09-27
CA2464396A1 (en) 2003-05-01
WO2003035898A1 (fr) 2003-05-01
EP1445327A4 (en) 2005-09-14
US7459268B2 (en) 2008-12-02

Similar Documents

Publication Publication Date Title
HK1094231A1 (en) Prebiotic effect analysis
ATE431427T1 (de) Verbessertes verfahren zum nachweis von atp
BR0116329A (pt) Aparelho e método para análise e aperfeiçoamento de produtos agrìcolas
ATE316147T1 (de) Enzymsensor
WO2007120699A3 (en) Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds & other chemicals
ATE330032T1 (de) Verfahren zur erhaltung der dns-integrität
WO2004083816A3 (en) Loss of heterozygosity of the dna markers in the 12q22-23 region
DK1399590T3 (da) Happier kortlægning
GB2410798A (en) Methods detecting, characterising and monitoring hydrocarbon reservoirs
NO20055025D0 (no) Multiplex screening for lysosomale lagringsforstyrrelser (LSD)
WO2004094992A3 (en) Methods for analysis of biological dataset profiles
ATE503021T1 (de) Verfahren zum nachweis von endoglykosidase aktivität
NO20042089L (no) Fremgangsmate for a screene legemiddel som virker pa cellevegg
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
DE60334923D1 (de) Tät
BRPI0414283A (pt) métodos, composições e kits para a concentração e detecção de microorganismos
NO20056085L (no) Fremgangsmate for kromatografisk analyse av en proteinlosning
DE602006019628D1 (de) Verfahren zum testen von enzymaktivität in einer histologischen probe
WO2007074469A3 (en) Method and system for compiling a source code
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
BRPI0413897A (pt) método para titulação in vitro de um atnc e sua aplicação a um método de avaliação e/ou de controle de um processo para obtenção de um produto biológico
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren
NO20025217D0 (no) FremgangsmÕte for screening av legemiddel som virker pÕ cellevegg
NO20082394L (no) Polypeptidmarkor for diagnostikk og vurdering av vaskulaere sykdommer
DK1192460T3 (da) Fremgangsmåde til påvisning af mastitis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application